Eris Lifesciences dividend history and dates
NSE: ERISBSE: 540596Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,121.20.
- Next results date: the board meets on 26 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15,199 Cr353rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 29 Jul 2026
- 23.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 20 May 2026
- 3.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.66%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 29 Jul 2026
- 19.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 29 Jul 2026
- 13.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 20 May 2026
- 0.59
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 37,94348.8% delivered
Next dividend, ex-date and record date
No dividend is announced. The last went ex on 29 May 2026: ₹7.21 a share.
All upcoming dividends ›Eris Lifesciences dividend calendar
Each payment in the month it went ex, as declared, ₹ a share at the time. Years running counted to the year to Mar 2026.
- Paid 2 years running, from the year to Mar 2025Paid years running. Consecutive years ending here in which a dividend was declared, counted from 2007.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | In the year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | ₹7.21 | ₹7.21 | |||||||||||
| 2025 | ₹7.35 | ₹7.35 | |||||||||||
| 2022 | ₹7.35 | ₹7.35 | |||||||||||
| 2021 | ₹6.01 | ₹6.01 | |||||||||||
| 2020 | ₹2.87 | ₹5.50 | ₹8.37 |
Interim or final dividendSpecial dividendNone that month
Dividends by year
Per share, for the year it was paid for: a dividend declared with a year's results counts in that year, even when it goes ex after the year ends.Eris Lifesciences buyback history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.Share of profit paid out, %, where the year's results are on record
Dividend payout. Dividends per share on the year end's share count × shares in issue ÷ profit to the company's own shareholders for the year × 100, on the consolidated accounts, which cover the group with its subsidiaries; empty where that year's results are not on record, show a loss or have no share count, and for a row that is not a full year.Eris Lifesciences dividend history
Every payment with its ex-date and record date, the latest years open.
2026
- May29Fri
₹7.21Interim
Ex-date and record date 29 May 2026
0.53%of the price
2025
- Feb13Thu
₹7.35Interim
Ex-date and record date 13 Feb 2025 · announced 7 Feb 2025
0.56%of the price
Earlier, 2020 to 2022
2022
- Aug11Thu
₹7.35Interim
Ex-date 11 Aug 2022 · record date 16 Aug 2022 · announced 5 Aug 2022
1.06%of the price
2021
- Aug5Thu
₹6.01Interim
Ex-date 5 Aug 2021 · record date 6 Aug 2021 · announced 29 Jul 2021
0.79%of the price
2020₹8.37 a share in 2 payments
- Aug13Thu
₹5.50Interim
Ex-date 13 Aug 2020 · record date 14 Aug 2020 · announced 4 Aug 2020
0.98%of the price - Mar19Thu
₹2.87Interim
Ex-date 19 Mar 2020 · record date 20 Mar 2020 · announced 11 Mar 2020
0.74%of the price
Grouped by the calendar year each went ex, so a year's total here can differ from the year it was paid for above. Of the price is the dividend as a share of the close on the session before its ex-date.